Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Rimas Lukas, ASCO 2023: The INDIGO phase III trial, vorasidenib in patients with IDH1/2 mutated grade 2 glioma
View
Dostarlimab for the Treatment of Endometrial Cancer: A Review
View
Highlights in gynaecological oncology: Domenica Lorusso, ESMO 2023
View
A voyage of discovery: Exploring the latest evidence for 1q21+
View
Johan de Munter: Reflections as President of EONS, hopes for 2024 and European Cancer Nursing Day 2023
View
Foreword – touchREVIEWS in Oncology & Haematology, Volume 19, Issue 2, 2023
View
Ryan Sullivan, AACR 2023: The STARBOARD phase III trial, encorafenib, binimetinib and pembrolizumab as a combination therapy for BRAF V600 mutant melanoma
View
Impact of T2D on efficacy of immune checkpoint inhibitors in patients with cancer: Alessio Cortellini
View
Olutasidenib for Adults with Relapsed or Refractory Acute Myeloid Leukaemia with Isocitrate Dehydrogenase 1 Mutation
View
Pamela Kearns: Exciting steps forward through collaborative clinical trials in paediatric oncology
View